CA2171563A1
(en)
*
|
1993-09-14 |
1995-03-23 |
Eric Le Cheminant |
Injection device
|
CA2551185C
(en)
*
|
1994-03-28 |
2007-10-30 |
Sdgi Holdings, Inc. |
Apparatus and method for anterior spinal stabilization
|
SE9403433D0
(sv)
|
1994-10-10 |
1994-10-10 |
Pharmacia Ab |
Injection device
|
SE9502285D0
(sv)
|
1995-06-22 |
1995-06-22 |
Pharmacia Ab |
Improvements related to injections
|
US6058321A
(en)
*
|
1995-09-07 |
2000-05-02 |
Swayze; Claude R. |
Instrument for continuously monitoring fetal heart rate and intermittently monitoring fetal blood pH and method of use
|
WO1997036625A1
(de)
|
1996-04-02 |
1997-10-09 |
Disetronic Licensing Ag |
Injektionsgerät
|
ES2180744T3
(es)
*
|
1996-04-02 |
2003-02-16 |
Disetronic Licensing Ag |
Aparato de inyeccion.
|
WO1998001172A1
(de)
*
|
1996-07-05 |
1998-01-15 |
Disetronic Licensing Ag |
Injektionsgerät zum injizieren von flüssigkeit
|
WO1998001171A1
(de)
|
1996-07-05 |
1998-01-15 |
Disetronic Licensing Ag |
Injektionsgerät zum injizieren von flüssigkeit
|
DE19717107B4
(de)
|
1997-04-23 |
2005-06-23 |
Disetronic Licensing Ag |
System aus Behältnis und Antriebsvorrichtung für einen Kolben, der in dem ein Medikamentfluid enthaltenden Behältnis gehalten ist
|
CN1269369C
(zh)
|
1997-04-24 |
2006-08-09 |
株式会社Ntt都科摩 |
移动通信方法和移动通信系统
|
DE19740187C1
(de)
*
|
1997-09-12 |
1999-04-15 |
Disetronic Licensing Ag |
Vorrichtung zur dosierten Ausschüttung eines injizierbaren Produkts
|
ATE267028T1
(de)
|
1997-11-17 |
2004-06-15 |
Tecpharma Licensing Ag |
Nadelpenetrationsvorrichtung
|
DE29820166U1
(de)
|
1997-11-19 |
1999-03-25 |
Medico Dev Investment Co |
Nadelanordnung für ein Injektionsgerät
|
US6482176B1
(en)
|
1997-11-27 |
2002-11-19 |
Disetronic Licensing Ag |
Method and device for controlling the introduction depth of an injection needle
|
DE19755125B4
(de)
*
|
1997-12-11 |
2006-04-20 |
Tecpharma Licensing Ag |
Nadelschutzvorrichtung für Injektionsgeräte
|
PT1047343E
(pt)
|
1998-01-12 |
2004-11-30 |
Alsensa Aps |
Unidade de injeccao
|
US6949111B2
(en)
|
1998-02-13 |
2005-09-27 |
Steven Schraga |
Lancet device
|
US5997509A
(en)
*
|
1998-03-06 |
1999-12-07 |
Cornell Research Foundation, Inc. |
Minimally invasive gene therapy delivery device and method
|
CA2229522A1
(en)
|
1998-04-15 |
1999-10-15 |
Thomas Randall Inkpen |
Needle aid
|
DE19822031C2
(de)
|
1998-05-15 |
2000-03-23 |
Disetronic Licensing Ag |
Autoinjektionsgerät
|
US6290679B1
(en)
|
1999-05-14 |
2001-09-18 |
Disetronic Licensing Ag |
Device for metered administration of an injectable product
|
DE19821933C1
(de)
|
1998-05-15 |
1999-11-11 |
Disetronic Licensing Ag |
Vorrichtung zur Verabreichung eines injizierbaren Produkts
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
DE19925904C1
(de)
|
1999-06-07 |
2001-02-01 |
Disetronic Licensing Ag |
Vorrichtung zur subkutanen Verabreichung eines injizierbaren Produkts
|
US20020095134A1
(en)
*
|
1999-10-14 |
2002-07-18 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US6843781B2
(en)
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US8465468B1
(en)
|
2000-06-29 |
2013-06-18 |
Becton, Dickinson And Company |
Intradermal delivery of substances
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US6494865B1
(en)
*
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US20020156453A1
(en)
*
|
1999-10-14 |
2002-10-24 |
Pettis Ronald J. |
Method and device for reducing therapeutic dosage
|
US7241275B2
(en)
*
|
1999-10-14 |
2007-07-10 |
Becton, Dickinson And Company |
Intradermal needle
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US20050070945A1
(en)
*
|
1999-11-02 |
2005-03-31 |
Steven Schraga |
Single use lancet assembly
|
US8814896B2
(en)
|
1999-11-02 |
2014-08-26 |
Stat Medical Devices, Inc. |
Single use lancet assembly
|
US6322575B1
(en)
|
2000-01-05 |
2001-11-27 |
Steven Schraga |
Lancet depth adjustment assembly
|
DE20006251U1
(de)
*
|
2000-04-05 |
2001-08-16 |
B D Medico Gmbh Mies |
Nadelschutzanordnung
|
US6508802B1
(en)
|
2000-05-23 |
2003-01-21 |
Cornell Research Foundation, Inc. |
Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart
|
US6547764B2
(en)
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
US20050008683A1
(en)
*
|
2000-06-29 |
2005-01-13 |
Becton Dickinson And Company |
Method for delivering interferons to the intradermal compartment
|
US20040175360A1
(en)
*
|
2000-06-29 |
2004-09-09 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
ES2765665T3
(es)
|
2000-08-02 |
2020-06-10 |
Becton Dickinson Co |
Sistema de aguja de pluma y pantalla protectora de seguridad
|
US6986760B2
(en)
*
|
2000-08-02 |
2006-01-17 |
Becton, Dickinson And Company |
Pen needle and safety shield system
|
DE10044383C2
(de)
*
|
2000-09-08 |
2003-02-06 |
Disetronic Licensing Ag |
Nadelschutzvorrichtung
|
DK1361890T3
(da)
*
|
2001-02-23 |
2011-06-27 |
Glaxosmithkline Biolog Sa |
Influenzavaccineformuleringer til intradermal indgift
|
JP2004536785A
(ja)
*
|
2001-02-23 |
2004-12-09 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
新規なワクチン
|
DK1383456T3
(da)
|
2001-03-27 |
2007-06-04 |
Lilly Co Eli |
Samlesæt, der indbefatter en sideaffyringsspröjtenål til fremstilling af et lægemiddel i en injektionspenindsats
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP1385560B1
(en)
*
|
2001-04-13 |
2018-05-16 |
Becton, Dickinson and Company |
Prefillable intradermal delivery device with hidden needle and passive shielding
|
WO2002083232A1
(en)
*
|
2001-04-13 |
2002-10-24 |
Becton, Dickinson And Company |
Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption
|
DE10293048T1
(de)
*
|
2001-04-27 |
2003-07-31 |
Glaxosmithkline Biolog Sa |
Neuer Impfstoff
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
CA2450711C
(en)
|
2001-06-13 |
2010-11-02 |
Steven Schraga |
Single use lancet device
|
BR0210628A
(pt)
*
|
2001-06-29 |
2004-08-10 |
Becton Dickinson Co |
Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
US20050010193A1
(en)
*
|
2002-05-06 |
2005-01-13 |
Laurent Philippe E. |
Novel methods for administration of drugs and devices useful thereof
|
US20030073609A1
(en)
*
|
2001-06-29 |
2003-04-17 |
Pinkerton Thomas C. |
Enhanced pharmacokinetic profile of intradermally delivered substances
|
US8048097B2
(en)
*
|
2001-08-14 |
2011-11-01 |
Steven Schraga |
Single use lancet assembly
|
US6918918B1
(en)
|
2001-08-14 |
2005-07-19 |
Steven Schraga |
Single use lancet assembly
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
ATE420687T1
(de)
|
2001-11-30 |
2009-01-15 |
Novo Nordisk As |
Nadelsicherheitsvorrichtung
|
US20050033230A1
(en)
*
|
2002-02-15 |
2005-02-10 |
Alchas Paul G. |
Prefillable intradermal delivery device with hidden needle and passive shielding
|
DE10207276A1
(de)
*
|
2002-02-21 |
2003-09-11 |
Disetronic Licensing Ag |
Nadel-Insertionsvorrichtung mit quer bewegbarem Halteelement
|
CH695758A5
(de)
*
|
2002-03-05 |
2006-08-31 |
Tecpharma Licensing Ag |
Kühlvorrichtung für Injektionsgeräte.
|
US8715309B2
(en)
|
2002-04-29 |
2014-05-06 |
Steven Schraga |
Lancet device
|
US20040039407A1
(en)
*
|
2002-04-29 |
2004-02-26 |
Steven Schraga |
Lancet device
|
US20060264886A9
(en)
*
|
2002-05-06 |
2006-11-23 |
Pettis Ronald J |
Method for altering insulin pharmacokinetics
|
AU2003230256B2
(en)
*
|
2002-05-06 |
2009-06-04 |
Becton, Dickinson And Company |
Method and device for controlling drug pharmacokinetics
|
MXPA05002270A
(es)
*
|
2002-08-30 |
2005-06-08 |
Becton Dickinson Co |
Metodo para controlar farmacocineticos de compuestos inmunomoduladores.
|
BRPI0407086B1
(pt)
|
2003-01-30 |
2021-10-13 |
Becton, Dickinson And Company |
Dispositivo de liberação de medicação
|
CN103074316B
(zh)
|
2003-05-22 |
2015-10-21 |
美国弗劳恩霍夫股份有限公司 |
用于表达、传递及纯化目标多肽的重组载体分子
|
EP1635876A4
(en)
*
|
2003-06-13 |
2009-05-06 |
Becton Dickinson Co |
IMPROVED INTRADERMAL ADMINISTRATION OF BIOACTIVE AGENTS
|
US8932264B2
(en)
*
|
2003-08-11 |
2015-01-13 |
Becton, Dickinson And Company |
Medication delivery pen assembly with needle locking safety shield
|
MXPA06002159A
(es)
*
|
2003-08-26 |
2006-05-22 |
Becton Dickinson Co |
Metodos para la administracion intradermica de agentes terapeuticos.
|
JP3100042U
(ja)
*
|
2003-08-26 |
2004-04-30 |
アルプス電気株式会社 |
テレビジョンチューナ
|
BRPI0414021B1
(pt)
|
2003-08-28 |
2023-09-26 |
Becton, Dickinson And Company |
Dispositivo de injeção intradérmica
|
AU2003270473A1
(en)
*
|
2003-09-09 |
2005-04-27 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
FR2861284B1
(fr)
*
|
2003-10-24 |
2005-12-30 |
Gaetan Terrasse |
Dispositif d'inoculation therapeutique et diagnostique
|
US20050256499A1
(en)
*
|
2004-03-03 |
2005-11-17 |
Pettis Ronald J |
Methods and devices for improving delivery of a substance to skin
|
US20050256182A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Sutter Diane E |
Formulations of anti-pain agents and methods of using the same
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060178686A1
(en)
*
|
2005-02-07 |
2006-08-10 |
Steven Schraga |
Single use lancet device
|
AU2006226459A1
(en)
|
2005-03-23 |
2006-09-28 |
Glaxosmithkline Biologicals S.A. |
Composition
|
WO2006107626A1
(en)
|
2005-04-04 |
2006-10-12 |
University Of Florida Research Foundation, Inc. |
Desferrithiocin polyether analogues
|
CN101378781B
(zh)
*
|
2005-08-03 |
2013-08-07 |
美国弗劳恩霍夫股份有限公司 |
制造免疫球蛋白的组合物和方法
|
TWI457133B
(zh)
*
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
US9267937B2
(en)
*
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
EP1984388B1
(en)
*
|
2006-02-13 |
2016-07-06 |
iBio, Inc. |
Hpv antigens, vaccine compositions, and related methods
|
US8124103B2
(en)
*
|
2006-02-13 |
2012-02-28 |
Fraunhofer Usa, Inc |
Influenza antigens, vaccine compositions, and related methods
|
US8277816B2
(en)
*
|
2006-02-13 |
2012-10-02 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
WO2007106415A2
(en)
*
|
2006-03-10 |
2007-09-20 |
Massachusetts Institute Of Technology |
Triggered self-assembly conjugates and nanosystems
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
EP2007435B1
(en)
|
2006-03-31 |
2019-12-18 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
US20090325944A1
(en)
*
|
2006-04-12 |
2009-12-31 |
Suzanne Walker Kahne |
Methods and Compositions for Modulating Glycosylation
|
EP2019691B1
(en)
|
2006-05-15 |
2020-08-12 |
Massachusetts Institute of Technology |
Polymers for functional particles
|
US9150626B2
(en)
*
|
2006-06-02 |
2015-10-06 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
BRPI0621886B1
(pt)
|
2006-07-17 |
2021-09-21 |
Glaxosmithkline Biologicals S.A |
Composição de vacina contra influenza monovalente, kit, método para a produção de uma composição de vacina contra influenza para uma situação pandêmica ou uma situação pré- pandêmica, e, usos de um antígeno de vírus da influenza ou preparação antigênica do mesmo e de um adjuvante em emulsão óleo-em-água, de um antígeno de vírus da influenza pandêmica ou preparação antigênica do antígeno de hemaglutinina do vírus da influenza e de um adjuvante em emulsão óleo-em-água e de um antígeno ou preparação antigênica de uma primeira cepa de influenza
|
US9115358B2
(en)
*
|
2006-08-11 |
2015-08-25 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
US20090269342A1
(en)
*
|
2006-08-14 |
2009-10-29 |
Massachusetts Institute Of Technology |
Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
|
AU2007284496A1
(en)
*
|
2006-08-14 |
2008-02-21 |
Massachusetts Institute Of Technology |
Glycan data mining system
|
JO3598B1
(ar)
*
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
US7811254B2
(en)
*
|
2006-10-18 |
2010-10-12 |
Meridian Medical Technologies, Inc. |
Autoinjector with needle depth adapter
|
SG177184A1
(en)
|
2006-12-01 |
2012-01-30 |
Anterios Inc |
Amphiphilic entity nanoparticles
|
CA2671850A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Massachusetts Institute Of Technology |
Delivery of nanoparticles and/or agents to cells
|
PT2114873E
(pt)
|
2006-12-26 |
2013-05-06 |
Lantheus Medical Imaging Inc |
Ligandos para imagiologia de inervação cardíaca
|
EP2952522B1
(en)
|
2007-01-31 |
2019-10-30 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
EP2134830A2
(en)
*
|
2007-02-09 |
2009-12-23 |
Massachusetts Institute of Technology |
Oscillating cell culture bioreactor
|
US8324397B2
(en)
|
2007-03-15 |
2012-12-04 |
University Of Florida Research Foundation, Inc. |
Desferrithiocin polyether analogues
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
KR101623985B1
(ko)
|
2007-03-28 |
2016-05-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
스티칭된 폴리펩티드
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ(アミノ酸)ターゲッティング部分
|
EP2152301A4
(en)
*
|
2007-04-28 |
2010-07-28 |
Fraunhofer Usa Inc |
TRYPANOSOME ANTIGENS, VACCINE COMPOSITIONS AND RELATED METHODS
|
KR20100045413A
(ko)
*
|
2007-06-14 |
2010-05-03 |
크루셀 스위츨랜드 아게 |
피내 인플루엔자 백신
|
US8524444B2
(en)
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
US8404252B2
(en)
*
|
2007-07-11 |
2013-03-26 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
US20110059130A1
(en)
*
|
2007-08-20 |
2011-03-10 |
Fraunhofer Usa, Inc. |
Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods
|
WO2009046314A2
(en)
*
|
2007-10-04 |
2009-04-09 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
CN105770878A
(zh)
|
2007-10-12 |
2016-07-20 |
麻省理工学院 |
疫苗纳米技术
|
WO2009089119A2
(en)
*
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
ES2729650T3
(es)
|
2008-03-13 |
2019-11-05 |
Becton Dickinson Co |
Conjunto de aguja de seguridad
|
CA2719209C
(en)
|
2008-03-13 |
2016-10-18 |
Becton, Dickinson And Company |
Safety pen needle assembly having shield for non-patient end
|
ES2615954T3
(es)
|
2008-03-13 |
2017-06-08 |
Becton, Dickinson And Company |
Conjunto de seguridad de aguja para pluma con protección de los extremos para el paciente y no para el paciente
|
JP5637982B2
(ja)
*
|
2008-04-09 |
2014-12-10 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
脂肪酸アミド加水分解酵素の阻害剤
|
CN102066405B
(zh)
*
|
2008-04-28 |
2015-09-30 |
哈佛大学校长及研究员协会 |
用于细胞穿透的超荷电蛋白
|
SG10201608732VA
(en)
|
2008-06-26 |
2016-12-29 |
Anterios Inc |
Dermal delivery
|
WO2010009271A2
(en)
|
2008-07-15 |
2010-01-21 |
Academia Sinica |
Glycan arrays on ptfe-like aluminum coated glass slides and related methods
|
CA2734991A1
(en)
*
|
2008-07-23 |
2010-01-28 |
Massachusetts Institute Of Technology |
Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
|
US20110144306A1
(en)
*
|
2008-07-23 |
2011-06-16 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
WO2010037046A1
(en)
|
2008-09-28 |
2010-04-01 |
Fraunhofer Usa, Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
WO2010077806A1
(en)
|
2008-12-15 |
2010-07-08 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways
|
US20110008867A1
(en)
*
|
2008-12-22 |
2011-01-13 |
Greenlight Biosciences |
Compositions and methods for the production of a compound
|
US8546564B2
(en)
|
2009-04-07 |
2013-10-01 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
US8541581B2
(en)
|
2009-04-07 |
2013-09-24 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
WO2010129023A2
(en)
|
2009-04-28 |
2010-11-11 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8957075B2
(en)
|
2009-06-01 |
2015-02-17 |
President And Fellows Of Harvard College |
O-GlcNAc transferase inhibitors and uses thereof
|
CN102510755A
(zh)
|
2009-07-13 |
2012-06-20 |
哈佛大学校长及研究员协会 |
双功能钉接多肽和其用途
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2776144C
(en)
|
2009-09-29 |
2020-10-27 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
EP2528615B1
(en)
|
2010-01-27 |
2020-05-13 |
Massachusetts Institute of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
WO2011097233A1
(en)
*
|
2010-02-03 |
2011-08-11 |
Infinity Pharmaceuticals, Inc. |
Fatty acid amide hydrolase inhibitors
|
US9180105B2
(en)
|
2010-03-08 |
2015-11-10 |
Sloan-Kettering Institute For Cancer Research |
CDC7 kinase inhibitors and uses thereof
|
WO2011119549A1
(en)
|
2010-03-22 |
2011-09-29 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
CA2798330A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
WO2011140516A2
(en)
|
2010-05-07 |
2011-11-10 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through enzyme relocation
|
MX367382B
(es)
|
2010-05-11 |
2019-08-19 |
Lantheus Medical Imaging Inc |
Composiciones, metodos y sistemas para la sintesis y el uso de agentes trazadores.
|
US9193989B2
(en)
|
2010-06-18 |
2015-11-24 |
Taiho Pharmaceutical Co., Ltd. |
PRPK-TPRKB modulators and uses thereof
|
EP2399631A1
(en)
*
|
2010-06-28 |
2011-12-28 |
Sanofi-Aventis Deutschland GmbH |
Auto-injector with injection damper
|
EP3578205A1
(en)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
WO2012021876A2
(en)
|
2010-08-13 |
2012-02-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2809284C
(en)
|
2010-08-31 |
2021-02-23 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
JP2013541528A
(ja)
|
2010-09-21 |
2013-11-14 |
マサチューセッツ インスティテュート オブ テクノロジー |
ヒト適応haポリペプチド、ワクチン、およびインフルエンザの処置
|
US8957026B2
(en)
|
2010-09-22 |
2015-02-17 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
RU2013120302A
(ru)
|
2010-10-01 |
2014-11-20 |
Модерна Терапьютикс, Инк. |
Сконструированные нуклеиновые кислоты и способы их применения
|
BR112013007946B1
(pt)
|
2010-10-04 |
2022-07-12 |
Massachusetts Institute Of Technology |
Composições farmacêuticas e imunogênicas compreendendo polipeptídeos de hemaglutinina
|
US9006178B2
(en)
*
|
2010-11-09 |
2015-04-14 |
Novo Nordisk A/S |
Double-acylated GLP-1 derivatives with a linker
|
EP2637669A4
(en)
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and their use
|
CN103648499B
(zh)
|
2011-01-10 |
2017-02-15 |
无限药品股份有限公司 |
用于制备异喹啉酮的方法及异喹啉酮的固体形式
|
CA2824317C
(en)
|
2011-01-19 |
2014-12-16 |
Terakine Therapeutics, Inc. |
Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia
|
CN106924216A
(zh)
|
2011-01-24 |
2017-07-07 |
安特里奥公司 |
纳米颗粒组合物、其制剂和它们的用途
|
ES2720648T3
(es)
|
2011-01-24 |
2019-07-23 |
Anterios Inc |
Composiciones de nanopartículas
|
KR20140003573A
(ko)
|
2011-01-24 |
2014-01-09 |
안테리오스, 인코퍼레이티드 |
오일 조성물
|
JP2014518609A
(ja)
|
2011-03-03 |
2014-08-07 |
テルサス ファーマシューティカルズ リミテッド ライアビリティ カンパニー |
C16:1n7−パルミトレアートを含む組成物および方法
|
WO2012135615A2
(en)
|
2011-03-30 |
2012-10-04 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
JP6061922B2
(ja)
|
2011-06-22 |
2017-01-18 |
ザ ジェネラル ホスピタル コーポレイション |
プロテイノパチーの処置方法
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
AU2012284091B2
(en)
|
2011-07-19 |
2015-11-12 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
CA2842524C
(en)
|
2011-07-22 |
2020-07-14 |
Massachusetts Institute Of Technology |
Activators of class i histone deacetylases (hdacs) and uses thereof
|
CN103998442B
(zh)
|
2011-08-29 |
2016-09-14 |
无限药品股份有限公司 |
杂环化合物及其用途
|
KR20190015765A
(ko)
|
2011-09-09 |
2019-02-14 |
랜티우스 메디컬 이메징, 인크. |
영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
|
SG2014014377A
(en)
|
2011-09-09 |
2014-05-29 |
Greenlight Biosciences Inc |
Cell-free preparation of carbapenems
|
EP2755693A4
(en)
|
2011-09-12 |
2015-05-20 |
Moderna Therapeutics Inc |
MODIFIED NUCLEIC ACIDS AND METHODS OF USE
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
US9428535B2
(en)
|
2011-10-03 |
2016-08-30 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
TWI643868B
(zh)
|
2011-10-18 |
2018-12-11 |
艾利倫治療公司 |
擬肽巨環化合物
|
EP3569598A1
(en)
|
2011-11-17 |
2019-11-20 |
Dana Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
LT2791160T
(lt)
|
2011-12-16 |
2022-06-10 |
Modernatx, Inc. |
Modifikuotos mrnr sudėtys
|
CA2859406C
(en)
|
2011-12-16 |
2020-08-25 |
University Of Florida Research Foundation, Inc. |
Uses of 4'-desferrithiocin analogs
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
EP2822572B1
(en)
|
2012-02-15 |
2020-06-10 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2864120A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
WO2013152279A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
WO2013151697A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
WO2013152277A2
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
CA2871160C
(en)
|
2012-05-10 |
2023-03-14 |
Massachusetts Institute Of Technology |
Agents for influenza neutralization
|
JP2015525794A
(ja)
|
2012-08-06 |
2015-09-07 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
乳児においてrsv及び百日咳菌に対する免疫応答を惹起するための方法
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
EP2885311B1
(en)
|
2012-08-18 |
2020-01-01 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
JP6506166B2
(ja)
|
2012-09-26 |
2019-04-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
プロリンロックドステープルドペプチドおよびその用途
|
WO2014055564A1
(en)
|
2012-10-01 |
2014-04-10 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
LT2909204T
(lt)
|
2012-10-12 |
2019-05-10 |
The Broad Institute, Inc. |
Gsk3 inhibitoriai ir jų panaudojimo būdai
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
EP2914256B1
(en)
|
2012-11-01 |
2019-07-31 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
HUE040126T2
(hu)
|
2012-11-01 |
2019-02-28 |
Infinity Pharmaceuticals Inc |
Rákok kezelése PI3 kináz izoform modulátorok alkalmazásával
|
EP2917203B1
(en)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Method for identifying myc inhibitors
|
MX2015006390A
(es)
|
2012-11-21 |
2015-08-05 |
Topokine Therapeutics Inc |
Metodos y composiciones para incrementar localmente la grasa corporal.
|
WO2014081507A1
(en)
|
2012-11-26 |
2014-05-30 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
JP6408478B2
(ja)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
|
US8940726B2
(en)
|
2012-12-21 |
2015-01-27 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
UA118548C2
(uk)
|
2012-12-21 |
2019-02-11 |
Епізайм, Інк. |
Тетрагідро- та дигідроізохіноліни як інгібітори prmt5 та їх застосування
|
US9611257B2
(en)
|
2012-12-21 |
2017-04-04 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
EP2935240A1
(en)
|
2012-12-21 |
2015-10-28 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
AU2013374345A1
(en)
|
2013-01-17 |
2015-08-06 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
CA2900008A1
(en)
|
2013-02-07 |
2014-08-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
JP6518597B2
(ja)
|
2013-02-07 |
2019-05-22 |
マサチューセッツ インスティテュート オブ テクノロジー |
H5インフルエンザのヒトへの適応
|
WO2014159813A1
(en)
|
2013-03-13 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
WO2014159969A1
(en)
|
2013-03-13 |
2014-10-02 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
NZ629037A
(en)
|
2013-03-15 |
2017-04-28 |
Infinity Pharmaceuticals Inc |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
US11246842B2
(en)
|
2014-12-18 |
2022-02-15 |
Windgap Medical, Inc. |
Method and compositions for dissolving or solubilizing therapeutic agents
|
EP2981285B1
(en)
|
2013-04-03 |
2020-06-03 |
N-Fold Llc |
Novel nanoparticle compositions
|
CA3130061A1
(en)
|
2013-04-04 |
2014-10-09 |
President And Fellows Of Harvard College |
Macrolides and methods of their preparation and use
|
WO2014169073A1
(en)
|
2013-04-09 |
2014-10-16 |
Massachusetts Institute Of Technology |
Drug delivery polymer and uses thereof
|
WO2014179464A1
(en)
|
2013-04-30 |
2014-11-06 |
Massachusetts Institute Of Technology |
Human adaptation of h3 influenza
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(uk)
|
2013-05-10 |
2018-06-16 |
|
|
US20140377258A1
(en)
|
2013-05-30 |
2014-12-25 |
Infinity Pharmaceuticals, Inc. |
Treatment Of Cancers Using PI3 Kinase Isoform Modulators
|
US10526375B2
(en)
|
2013-06-05 |
2020-01-07 |
Massachusetts Institute Of Technology |
Human Adaptation of H7 HA
|
WO2014201127A2
(en)
|
2013-06-11 |
2014-12-18 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
EP3008081B1
(en)
|
2013-06-14 |
2017-08-30 |
President and Fellows of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
RU2016105108A
(ru)
|
2013-07-25 |
2017-08-30 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Ингибиторы факторов транскрипции и их применение
|
JP6483687B2
(ja)
|
2013-08-05 |
2019-03-13 |
グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. |
プロテアーゼ切断部位を有する操作されたタンパク質
|
JP6564367B2
(ja)
|
2013-08-05 |
2019-08-21 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
併用免疫原性組成物
|
EP3041484B1
(en)
|
2013-09-06 |
2021-03-03 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
WO2015048121A1
(en)
|
2013-09-25 |
2015-04-02 |
University Of Florida Research Foundation, Inc. |
Vitamin c prodrugs and uses thereof
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MX2021012208A
(es)
|
2013-10-04 |
2023-01-19 |
Infinity Pharmaceuticals Inc |
Compuestos heterocíclicos y usos de los mismos.
|
US9982009B2
(en)
|
2013-10-15 |
2018-05-29 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
ES2676734T3
(es)
|
2013-10-18 |
2018-07-24 |
Syros Pharmaceuticals, Inc. |
Compuestos heteroatómicos útiles para el tratamiento de enfermedades proliferativas
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MX355330B
(es)
|
2013-11-01 |
2018-04-16 |
Kala Pharmaceuticals Inc |
Formas cristalinas de compuestos terapeuticos y sus usos.
|
EP2883563B1
(en)
|
2013-12-10 |
2021-03-31 |
Becton, Dickinson and Company |
Active safety pen needle assembly
|
US9623194B2
(en)
|
2013-12-10 |
2017-04-18 |
Becton, Dickinson And Company |
Passive safety pen needle assembly
|
EP3505521A1
(en)
|
2013-12-24 |
2019-07-03 |
President and Fellows of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
KR20160104727A
(ko)
|
2014-01-16 |
2016-09-05 |
아카데미아 시니카 |
암의 치료 및 검출을 위한 조성물 및 방법
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
JP6625071B2
(ja)
|
2014-03-07 |
2019-12-25 |
ザ アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ |
慢性疼痛用のナトリウムチャネルを標的とする非麻薬性crmp2ペプチド
|
CA2943075C
(en)
|
2014-03-19 |
2023-02-28 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
CN106415244B
(zh)
|
2014-03-27 |
2020-04-24 |
中央研究院 |
反应性标记化合物及其用途
|
DK3122375T3
(da)
|
2014-03-28 |
2021-05-25 |
Univ Washington Through Its Center For Commercialization |
Vacciner mod bryst- og ovariecancer
|
WO2015164604A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
US10017477B2
(en)
|
2014-04-23 |
2018-07-10 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10039816B2
(en)
|
2014-04-30 |
2018-08-07 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
AU2015264122B2
(en)
|
2014-05-21 |
2021-02-04 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
TWI670078B
(zh)
|
2014-05-27 |
2019-09-01 |
中央研究院 |
抗cd20醣抗體及其用途
|
JP7062361B2
(ja)
|
2014-05-27 |
2022-05-06 |
アカデミア シニカ |
抗her2糖操作抗体群およびその使用
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
JP7093612B2
(ja)
|
2014-05-27 |
2022-06-30 |
アカデミア シニカ |
Bacteroides由来のフコシダーゼおよびそれを使用する方法
|
US11332523B2
(en)
|
2014-05-28 |
2022-05-17 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
BR112016028816A8
(pt)
|
2014-06-13 |
2021-07-20 |
Glaxosmithkline Biologicals Sa |
combinação imunogênica, método para obter uma resposta imunológica específica, uso de uma combinação imunogênica, e, regime de vacinação para prevenção, redução ou tratamento de infecção por vírus sincicial respiratório
|
CN110526912B
(zh)
|
2014-06-19 |
2023-02-14 |
武田药品工业株式会社 |
用于激酶抑制的杂芳基化合物
|
US10188661B2
(en)
|
2014-06-27 |
2019-01-29 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
CN106715458A
(zh)
|
2014-07-18 |
2017-05-24 |
华盛顿大学 |
癌症疫苗组合物及其使用方法
|
WO2016025643A1
(en)
|
2014-08-12 |
2016-02-18 |
Massachusetts Institute Of Technology |
Brush-poly(glycoamidoamine)-lipids and uses thereof
|
JP6899321B2
(ja)
|
2014-09-08 |
2021-07-07 |
アカデミア シニカAcademia Sinica |
糖脂質を使用するヒトiNKT細胞活性化
|
CN106999541A
(zh)
|
2014-09-24 |
2017-08-01 |
艾瑞朗医疗公司 |
拟肽大环化合物及其用途
|
CA2961029A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
LT3209647T
(lt)
|
2014-10-21 |
2020-09-25 |
Ariad Pharmaceuticals, Inc. |
Kristalinės 5-chlor-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il) piperidin-1-il]pirimidin-2,4-diamino formos
|
JP2017533238A
(ja)
|
2014-10-28 |
2017-11-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
抗原特異的寛容のための組成物及び方法
|
WO2016077125A1
(en)
|
2014-11-10 |
2016-05-19 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
US10253045B2
(en)
|
2014-11-26 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
CA2969467A1
(en)
|
2014-12-10 |
2016-06-16 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
|
EP3237066B1
(en)
|
2014-12-23 |
2020-10-21 |
Sloan-Kettering Institute for Cancer Research |
Polymorph of granaticin b
|
JP6854762B2
(ja)
|
2014-12-23 |
2021-04-07 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼ7(cdk7)の阻害剤
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
CA2972072A1
(en)
|
2015-01-24 |
2016-07-28 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
MX2017011834A
(es)
|
2015-03-20 |
2018-04-11 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos y usos de los mismos.
|
JP6861166B2
(ja)
|
2015-03-27 |
2021-04-21 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼの阻害剤
|
KR20180002636A
(ko)
|
2015-03-30 |
2018-01-08 |
그린라이트 바이오사이언시스, 아이엔씨. |
리보핵산의 무세포 생산
|
AU2016255770A1
(en)
|
2015-04-27 |
2017-11-16 |
University Of Florida Research Foundation, Incorporated |
Metabolically programmed metal chelators and uses thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
AU2016276963C1
(en)
|
2015-06-12 |
2021-08-05 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
SI3310764T1
(sl)
|
2015-06-19 |
2023-06-30 |
Massachusetts Institute Of Technology |
Z alkenilom substituirani 2,5-piperazindioni in njihova uporaba v sestavkih za dostavo sredstva subjektu ali celici
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2996978A1
(en)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
CN108368161A
(zh)
|
2015-09-10 |
2018-08-03 |
艾瑞朗医疗公司 |
作为mcl-1调节剂的拟肽大环化合物
|
ES2910425T3
(es)
|
2015-09-17 |
2022-05-12 |
Modernatx Inc |
Compuestos y composiciones para la administración intracelular de agentes terapéuticos
|
DK3350333T3
(da)
|
2015-09-17 |
2022-01-31 |
Modernatx Inc |
Polynukleotider, der indeholder en stabiliserende haleregion
|
WO2017059389A1
(en)
|
2015-10-01 |
2017-04-06 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising a statin for use in methods of adipolysis
|
JPWO2017073658A1
(ja)
*
|
2015-10-30 |
2018-08-30 |
テルモ株式会社 |
グリップ及び注射器組立体
|
SI3394030T1
(sl)
|
2015-12-22 |
2022-04-29 |
Modernatx, Inc. |
Sestave za doziranje sredstev v celice
|
USD806246S1
(en)
|
2016-02-25 |
2017-12-26 |
Steven Schraga |
Lancet cover
|
TW201808978A
(zh)
|
2016-03-08 |
2018-03-16 |
中央研究院 |
N-聚醣及其陣列之模組化合成方法
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
RU2018138975A
(ru)
|
2016-04-06 |
2020-05-12 |
Гринлайт Байосайенсис, Инк. |
Бесклеточная продукция рибонуклеиновой кислоты
|
WO2017210592A1
(en)
|
2016-06-03 |
2017-12-07 |
Sanofi Pasteur Inc. |
Modification of engineered influenza hemagglutinin polypeptides
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA3027201A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
JP7001686B2
(ja)
|
2016-08-05 |
2022-02-04 |
サノフィ パスツール インコーポレイティッド |
多価肺炎球菌多糖体-タンパク質コンジュゲート組成物
|
JP7001687B2
(ja)
|
2016-08-05 |
2022-02-04 |
サノフィ パスツール インコーポレイティッド |
多価肺炎球菌多糖体-タンパク質コンジュゲート組成物
|
CN109963868B
(zh)
|
2016-08-22 |
2023-11-14 |
醣基生医股份有限公司 |
抗体、结合片段及使用方法
|
US20180085555A1
(en)
*
|
2016-09-26 |
2018-03-29 |
Boston Scientific Scimed, Inc. |
Injection catheter
|
EP3538067A1
(en)
|
2016-11-08 |
2019-09-18 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
CA3044219A1
(en)
|
2016-11-21 |
2018-05-24 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
HUE060693T2
(hu)
|
2017-03-15 |
2023-04-28 |
Modernatx Inc |
Vegyület és készítmények terápiás szerek intracelluláris bejuttatására
|
US11969506B2
(en)
|
2017-03-15 |
2024-04-30 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
AU2018249558A1
(en)
|
2017-04-05 |
2019-11-07 |
Biogen Ma Inc. |
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
KR102571743B1
(ko)
|
2017-10-11 |
2023-08-29 |
그린라이트 바이오사이언시스, 아이엔씨. |
뉴클레오시드 트리포스페이트 및 리보핵산 생산을 위한 방법 및 조성물
|
EP3717033A4
(en)
|
2017-12-01 |
2021-08-25 |
North Carolina State University |
FIBRIN PARTICLES AND THEIR PRODUCTION METHODS
|
CN113056268A
(zh)
|
2018-09-13 |
2021-06-29 |
艾里奥治疗公司 |
纤溶酶原激活物抑制剂1(pai-1)抑制剂和其用途
|
JP2022500452A
(ja)
|
2018-09-13 |
2022-01-04 |
エイリオン セラピューティクス, インコーポレイテッド |
プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI−1)阻害剤(inhibitor)の使用
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
JP2022501367A
(ja)
|
2018-09-20 |
2022-01-06 |
モデルナティエックス インコーポレイテッドModernaTX, Inc. |
脂質ナノ粒子の調製及びその投与方法
|
WO2020117564A1
(en)
|
2018-12-03 |
2020-06-11 |
Eirion Therapeutics, Inc. |
Improved delivery of large agents
|
US20230072397A1
(en)
|
2019-01-16 |
2023-03-09 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
US20230159491A1
(en)
|
2019-01-16 |
2023-05-25 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
MX2021009245A
(es)
|
2019-01-31 |
2021-11-12 |
Modernatx Inc |
Metodos de preparacion de nanoparticulas lipidicas.
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
US20220296503A1
(en)
|
2019-05-14 |
2022-09-22 |
Eirion Therapeutics, Inc. |
Delaying peak effect and/or extending duration of response
|
CN110236781B
(zh)
*
|
2019-06-13 |
2021-06-29 |
南京医科大学眼科医院 |
一次性无菌可调节用治疗针
|
JP2022543773A
(ja)
|
2019-07-31 |
2022-10-14 |
モデルナティエックス インコーポレイテッド |
免疫細胞へのrna干渉剤の送達のための組成物及び方法
|
CN114728050A
(zh)
|
2019-07-31 |
2022-07-08 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物及其使用方法
|
CA3158103A1
(en)
|
2019-11-13 |
2021-05-20 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2021155274A1
(en)
|
2020-01-31 |
2021-08-05 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
US20230390296A1
(en)
|
2020-10-30 |
2023-12-07 |
Keio University |
Novel treatment and prevention of sarcopenia-related diseases
|
EP4238979A1
(en)
|
2020-10-30 |
2023-09-06 |
Xeno-Interface Inc. |
Beta-strand type crosslinked peptide
|
AR124267A1
(es)
|
2020-12-09 |
2023-03-01 |
Genentech Inc |
Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos
|
WO2022192176A1
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
CA3233926A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
CA3237134A1
(en)
|
2021-11-05 |
2023-05-11 |
Timothy ALEFANTIS |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
CA3237139A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
TW202333654A
(zh)
|
2021-12-16 |
2023-09-01 |
美商現代公司 |
用於製備脂質奈米顆粒之方法
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023172592A1
(en)
*
|
2022-03-11 |
2023-09-14 |
Amgen Inc. |
Adjustable depth autoinjector
|
WO2023177579A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|
WO2024091918A2
(en)
|
2022-10-25 |
2024-05-02 |
Modernatx, Inc. |
Methods of lipid nanoparticle production in cross-mixers
|